These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 29329518

  • 1. The use of eculizumab in gemcitabine induced thrombotic microangiopathy.
    Krishnappa V, Gupta M, Shah H, Das A, Tanphaichitr N, Novak R, Raina R.
    BMC Nephrol; 2018 Jan 12; 19(1):9. PubMed ID: 29329518
    [Abstract] [Full Text] [Related]

  • 2. [Clinical efficacy of eculizumab as treatment of gemcitabine-induced thrombotic microangiopathy: A case report].
    Rogier T, Gerfaud-Valentin M, Pouteil-Noble C, Taleb A, Guillet M, Noel A, Broussolle C, Sève P.
    Rev Med Interne; 2016 Oct 12; 37(10):701-704. PubMed ID: 26833144
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Gemcitabine-induced thrombotic microangiopathy: Can we improve screening and treatment?].
    Charmetant X, Jolivot A, Fournier T, Puthet JC, Cassier P, Lemoine S, Juillard L.
    Nephrol Ther; 2017 Jun 12; 13(4):251-254. PubMed ID: 28499586
    [Abstract] [Full Text] [Related]

  • 7. Gemcitabine-induced hemolytic-uremic syndrome treated with eculizumab or plasmapheresis: two case reports
.
    López Rubio ME, Rodado Martínez R, Illescas ML, Mateo Bosch E, Martinez Díaz M, de la Vara Inesta L, Cabezuelo B, Morales Albuja ME, Lucas Guillén E, Jimeno García L.
    Clin Nephrol; 2017 Feb 12; 87 (2017)(2):100-106. PubMed ID: 27879189
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gemcitabine-induced thrombotic microangiopathy.
    Richmond J, Gilbar P, Abro E.
    Intern Med J; 2013 Nov 12; 43(11):1240-2. PubMed ID: 24237646
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report.
    Kourouklaris A, Ioannou K, Athanasiou I, Panagidou A, Demetriou K, Zavros M.
    J Med Case Rep; 2014 Sep 14; 8():307. PubMed ID: 25219386
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial.
    Fakhouri F, Hourmant M, Campistol JM, Cataland SR, Espinosa M, Gaber AO, Menne J, Minetti EE, Provôt F, Rondeau E, Ruggenenti P, Weekers LE, Ogawa M, Bedrosian CL, Legendre CM.
    Am J Kidney Dis; 2016 Jul 14; 68(1):84-93. PubMed ID: 27012908
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pregnancy associated TMA in 13-year-old patient successfully treated with Eculizumab: case report.
    Cody E, Claes D, Taylor V, Erkan E.
    BMC Nephrol; 2022 Apr 15; 23(1):147. PubMed ID: 35428247
    [Abstract] [Full Text] [Related]

  • 16. Complement-mediated thrombotic microangiopathy secondary to sepsis-induced disseminated intravascular coagulation successfully treated with eculizumab: A case report.
    Abe T, Sasaki A, Ueda T, Miyakawa Y, Ochiai H.
    Medicine (Baltimore); 2017 Feb 15; 96(6):e6056. PubMed ID: 28178155
    [Abstract] [Full Text] [Related]

  • 17. Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: Case series and review of literature.
    Kello N, Khoury LE, Marder G, Furie R, Zapantis E, Horowitz DL.
    Semin Arthritis Rheum; 2019 Aug 15; 49(1):74-83. PubMed ID: 30598332
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reversible renal-limited thrombotic microangiopathy due to gemcitabine-dexamethasone-cisplatin therapy: a case report.
    Nishikubo M, Shimomura Y, Hiramoto N, Sawamura N, Yamaguchi T, Hara S, Ishikawa T.
    BMC Nephrol; 2021 May 12; 22(1):175. PubMed ID: 33980166
    [Abstract] [Full Text] [Related]

  • 20. [A case of thrombotic microangiopathy during chemotherapy with gemcitabine in a patient with pancreatic cancer].
    Kashima H, Minami R, Ozawa T, Matsumoto A, Kimura Y, Takeda Y, Ueo T, Okano A, Kusumi F, Ohana M.
    Nihon Shokakibyo Gakkai Zasshi; 2022 May 12; 119(3):259-266. PubMed ID: 35264490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.